DGIST researchers developed a deep learning model that classifies lung cancer exosomes based on physical properties measured by atomic force microscopy.
Key Details
- 1DGIST team used AFM to measure nanomechanical properties (stiffness, height-to-radius) of exosomes from NSCLC cell lines with different genetic mutations.
- 2AI model (DenseNet-121) classified exosomes by origin, achieving 96% accuracy and AUC of 0.92.
- 3Exosome stiffness reflected KRAS and EGFR mutations in their respective lung cancer cell lines.
- 4The method enables high-precision, label-free, liquid biopsy-based lung cancer diagnosis.
- 5Study published July 8, 2025, in Analytical Chemistry.
Why It Matters
This approach could offer a rapid, non-invasive way to diagnose lung cancer genetic mutations, reducing the need for tissue biopsies. Leveraging AI with nanomechanical imaging pushes boundaries in early cancer detection and personalized medicine.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.